nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Azotaemia—Vincristine—colon cancer	0.0244	0.0244	CcSEcCtD
Vancomycin—Rash macular—Capecitabine—colon cancer	0.0206	0.0206	CcSEcCtD
Vancomycin—Serum creatinine increased—Irinotecan—colon cancer	0.0206	0.0206	CcSEcCtD
Vancomycin—Necrosis—Fluorouracil—colon cancer	0.0154	0.0154	CcSEcCtD
Vancomycin—Extravasation—Vincristine—colon cancer	0.0149	0.0149	CcSEcCtD
Vancomycin—Extravasation—Irinotecan—colon cancer	0.0145	0.0145	CcSEcCtD
Vancomycin—Tenderness—Fluorouracil—colon cancer	0.0139	0.0139	CcSEcCtD
Vancomycin—Extravasation—Fluorouracil—colon cancer	0.0139	0.0139	CcSEcCtD
Vancomycin—Serum creatinine increased—Capecitabine—colon cancer	0.0138	0.0138	CcSEcCtD
Vancomycin—Azotaemia—Methotrexate—colon cancer	0.0118	0.0118	CcSEcCtD
Vancomycin—Fungal infection—Capecitabine—colon cancer	0.011	0.011	CcSEcCtD
Vancomycin—Thrombophlebitis—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Vancomycin—Deafness—Vincristine—colon cancer	0.0105	0.0105	CcSEcCtD
Vancomycin—Rigors—Capecitabine—colon cancer	0.0104	0.0104	CcSEcCtD
Vancomycin—Thrombophlebitis—Fluorouracil—colon cancer	0.0102	0.0102	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Irinotecan—colon cancer	0.00973	0.00973	CcSEcCtD
Vancomycin—Renal impairment—Irinotecan—colon cancer	0.00965	0.00965	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Irinotecan—colon cancer	0.00949	0.00949	CcSEcCtD
Vancomycin—Dermatitis bullous—Fluorouracil—colon cancer	0.0092	0.0092	CcSEcCtD
Vancomycin—Hearing impaired—Capecitabine—colon cancer	0.00889	0.00889	CcSEcCtD
Vancomycin—Blood creatinine increased—Irinotecan—colon cancer	0.0086	0.0086	CcSEcCtD
Vancomycin—Hypokalaemia—Irinotecan—colon cancer	0.00836	0.00836	CcSEcCtD
Vancomycin—Fungal infection—Methotrexate—colon cancer	0.00816	0.00816	CcSEcCtD
Vancomycin—Necrosis—Methotrexate—colon cancer	0.00803	0.00803	CcSEcCtD
Vancomycin—Neutropenia—Vincristine—colon cancer	0.00762	0.00762	CcSEcCtD
Vancomycin—Eosinophilia—Fluorouracil—colon cancer	0.00753	0.00753	CcSEcCtD
Vancomycin—Neutropenia—Irinotecan—colon cancer	0.00742	0.00742	CcSEcCtD
Vancomycin—Extravasation—Methotrexate—colon cancer	0.00722	0.00722	CcSEcCtD
Vancomycin—Phlebitis—Capecitabine—colon cancer	0.00713	0.00713	CcSEcCtD
Vancomycin—Thrombophlebitis—Capecitabine—colon cancer	0.0071	0.0071	CcSEcCtD
Vancomycin—Renal failure—Irinotecan—colon cancer	0.00696	0.00696	CcSEcCtD
Vancomycin—Deafness—Capecitabine—colon cancer	0.00687	0.00687	CcSEcCtD
Vancomycin—Infestation NOS—Fluorouracil—colon cancer	0.00678	0.00678	CcSEcCtD
Vancomycin—Infestation—Fluorouracil—colon cancer	0.00678	0.00678	CcSEcCtD
Vancomycin—Urinary tract infection—Fluorouracil—colon cancer	0.00659	0.00659	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Capecitabine—colon cancer	0.00651	0.00651	CcSEcCtD
Vancomycin—Bradycardia—Irinotecan—colon cancer	0.00647	0.00647	CcSEcCtD
Vancomycin—Renal impairment—Capecitabine—colon cancer	0.00646	0.00646	CcSEcCtD
Vancomycin—Vasculitis—Methotrexate—colon cancer	0.00646	0.00646	CcSEcCtD
Vancomycin—Dermatitis bullous—Capecitabine—colon cancer	0.00643	0.00643	CcSEcCtD
Vancomycin—Connective tissue disorder—Vincristine—colon cancer	0.00641	0.00641	CcSEcCtD
Vancomycin—Agranulocytosis—Fluorouracil—colon cancer	0.00632	0.00632	CcSEcCtD
Vancomycin—Connective tissue disorder—Irinotecan—colon cancer	0.00624	0.00624	CcSEcCtD
Vancomycin—Flushing—Irinotecan—colon cancer	0.0059	0.0059	CcSEcCtD
Vancomycin—Blood creatinine increased—Capecitabine—colon cancer	0.00576	0.00576	CcSEcCtD
Vancomycin—Chills—Irinotecan—colon cancer	0.0057	0.0057	CcSEcCtD
Vancomycin—Hypokalaemia—Capecitabine—colon cancer	0.00559	0.00559	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00553	0.00553	CcSEcCtD
Vancomycin—Back pain—Vincristine—colon cancer	0.00549	0.00549	CcSEcCtD
Vancomycin—Flatulence—Irinotecan—colon cancer	0.00545	0.00545	CcSEcCtD
Vancomycin—Back pain—Irinotecan—colon cancer	0.00535	0.00535	CcSEcCtD
Vancomycin—Muscle spasms—Irinotecan—colon cancer	0.00532	0.00532	CcSEcCtD
Vancomycin—Erythema—Fluorouracil—colon cancer	0.0053	0.0053	CcSEcCtD
Vancomycin—Thrombophlebitis—Methotrexate—colon cancer	0.00528	0.00528	CcSEcCtD
Vancomycin—Anaemia—Vincristine—colon cancer	0.00525	0.00525	CcSEcCtD
Vancomycin—Anaemia—Irinotecan—colon cancer	0.00511	0.00511	CcSEcCtD
Vancomycin—Vertigo—Vincristine—colon cancer	0.0051	0.0051	CcSEcCtD
Vancomycin—Vertigo—Irinotecan—colon cancer	0.00497	0.00497	CcSEcCtD
Vancomycin—Neutropenia—Capecitabine—colon cancer	0.00497	0.00497	CcSEcCtD
Vancomycin—Anaemia—Fluorouracil—colon cancer	0.00489	0.00489	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Methotrexate—colon cancer	0.00485	0.00485	CcSEcCtD
Vancomycin—Infestation NOS—Capecitabine—colon cancer	0.00474	0.00474	CcSEcCtD
Vancomycin—Infestation—Capecitabine—colon cancer	0.00474	0.00474	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Methotrexate—colon cancer	0.00473	0.00473	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00469	0.00469	CcSEcCtD
Vancomycin—Renal failure—Capecitabine—colon cancer	0.00466	0.00466	CcSEcCtD
Vancomycin—Anaphylactic shock—Vincristine—colon cancer	0.00463	0.00463	CcSEcCtD
Vancomycin—Infection—Vincristine—colon cancer	0.0046	0.0046	CcSEcCtD
Vancomycin—Urinary tract infection—Capecitabine—colon cancer	0.0046	0.0046	CcSEcCtD
Vancomycin—Nervous system disorder—Vincristine—colon cancer	0.00454	0.00454	CcSEcCtD
Vancomycin—Thrombocytopenia—Vincristine—colon cancer	0.00454	0.00454	CcSEcCtD
Vancomycin—Anaphylactic shock—Irinotecan—colon cancer	0.00451	0.00451	CcSEcCtD
Vancomycin—Infection—Irinotecan—colon cancer	0.00448	0.00448	CcSEcCtD
Vancomycin—Nervous system disorder—Irinotecan—colon cancer	0.00443	0.00443	CcSEcCtD
Vancomycin—Agranulocytosis—Capecitabine—colon cancer	0.00442	0.00442	CcSEcCtD
Vancomycin—Thrombocytopenia—Irinotecan—colon cancer	0.00442	0.00442	CcSEcCtD
Vancomycin—Hypotension—Vincristine—colon cancer	0.00433	0.00433	CcSEcCtD
Vancomycin—Bradycardia—Capecitabine—colon cancer	0.00433	0.00433	CcSEcCtD
Vancomycin—Anaphylactic shock—Fluorouracil—colon cancer	0.00432	0.00432	CcSEcCtD
Vancomycin—Infection—Fluorouracil—colon cancer	0.00429	0.00429	CcSEcCtD
Vancomycin—Nervous system disorder—Fluorouracil—colon cancer	0.00424	0.00424	CcSEcCtD
Vancomycin—Thrombocytopenia—Fluorouracil—colon cancer	0.00423	0.00423	CcSEcCtD
Vancomycin—Tachycardia—Fluorouracil—colon cancer	0.00422	0.00422	CcSEcCtD
Vancomycin—Hypotension—Irinotecan—colon cancer	0.00422	0.00422	CcSEcCtD
Vancomycin—Insomnia—Vincristine—colon cancer	0.00419	0.00419	CcSEcCtD
Vancomycin—Oedema peripheral—Capecitabine—colon cancer	0.00419	0.00419	CcSEcCtD
Vancomycin—Connective tissue disorder—Capecitabine—colon cancer	0.00418	0.00418	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00412	0.00412	CcSEcCtD
Vancomycin—Insomnia—Irinotecan—colon cancer	0.00408	0.00408	CcSEcCtD
Vancomycin—Hypotension—Fluorouracil—colon cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Dyspnoea—Irinotecan—colon cancer	0.00402	0.00402	CcSEcCtD
Vancomycin—Erythema multiforme—Capecitabine—colon cancer	0.00402	0.00402	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vincristine—colon cancer	0.004	0.004	CcSEcCtD
Vancomycin—Fatigue—Vincristine—colon cancer	0.004	0.004	CcSEcCtD
Vancomycin—Tinnitus—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Vancomycin—Pain—Vincristine—colon cancer	0.00396	0.00396	CcSEcCtD
Vancomycin—Constipation—Vincristine—colon cancer	0.00396	0.00396	CcSEcCtD
Vancomycin—Flushing—Capecitabine—colon cancer	0.00395	0.00395	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—colon cancer	0.00391	0.00391	CcSEcCtD
Vancomycin—Insomnia—Fluorouracil—colon cancer	0.00391	0.00391	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Irinotecan—colon cancer	0.0039	0.0039	CcSEcCtD
Vancomycin—Fatigue—Irinotecan—colon cancer	0.00389	0.00389	CcSEcCtD
Vancomycin—Constipation—Irinotecan—colon cancer	0.00386	0.00386	CcSEcCtD
Vancomycin—Pain—Irinotecan—colon cancer	0.00386	0.00386	CcSEcCtD
Vancomycin—Dyspnoea—Fluorouracil—colon cancer	0.00385	0.00385	CcSEcCtD
Vancomycin—Chills—Capecitabine—colon cancer	0.00381	0.00381	CcSEcCtD
Vancomycin—Gastrointestinal pain—Vincristine—colon cancer	0.00379	0.00379	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00373	0.00373	CcSEcCtD
Vancomycin—Erythema—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Vancomycin—Malnutrition—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—colon cancer	0.0037	0.0037	CcSEcCtD
Vancomycin—Pain—Fluorouracil—colon cancer	0.0037	0.0037	CcSEcCtD
Vancomycin—Gastrointestinal pain—Irinotecan—colon cancer	0.00369	0.00369	CcSEcCtD
Vancomycin—Abdominal pain—Vincristine—colon cancer	0.00366	0.00366	CcSEcCtD
Vancomycin—Body temperature increased—Vincristine—colon cancer	0.00366	0.00366	CcSEcCtD
Vancomycin—Flatulence—Capecitabine—colon cancer	0.00365	0.00365	CcSEcCtD
Vancomycin—Back pain—Capecitabine—colon cancer	0.00358	0.00358	CcSEcCtD
Vancomycin—Body temperature increased—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Vancomycin—Abdominal pain—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Vancomycin—Muscle spasms—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—colon cancer	0.00353	0.00353	CcSEcCtD
Vancomycin—Infestation—Methotrexate—colon cancer	0.00353	0.00353	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0035	0.0035	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—colon cancer	0.00347	0.00347	CcSEcCtD
Vancomycin—Urticaria—Fluorouracil—colon cancer	0.00343	0.00343	CcSEcCtD
Vancomycin—Anaemia—Capecitabine—colon cancer	0.00342	0.00342	CcSEcCtD
Vancomycin—Body temperature increased—Fluorouracil—colon cancer	0.00342	0.00342	CcSEcCtD
Vancomycin—Hypersensitivity—Vincristine—colon cancer	0.00341	0.00341	CcSEcCtD
Vancomycin—Vertigo—Capecitabine—colon cancer	0.00332	0.00332	CcSEcCtD
Vancomycin—Hypersensitivity—Irinotecan—colon cancer	0.00332	0.00332	CcSEcCtD
Vancomycin—Asthenia—Vincristine—colon cancer	0.00332	0.00332	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—colon cancer	0.00329	0.00329	CcSEcCtD
Vancomycin—Palpitations—Capecitabine—colon cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Asthenia—Irinotecan—colon cancer	0.00324	0.00324	CcSEcCtD
Vancomycin—Hypersensitivity—Fluorouracil—colon cancer	0.00318	0.00318	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00313	0.00313	CcSEcCtD
Vancomycin—Dizziness—Vincristine—colon cancer	0.00306	0.00306	CcSEcCtD
Vancomycin—Pruritus—Fluorouracil—colon cancer	0.00306	0.00306	CcSEcCtD
Vancomycin—Infection—Capecitabine—colon cancer	0.003	0.003	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—colon cancer	0.00299	0.00299	CcSEcCtD
Vancomycin—Dizziness—Irinotecan—colon cancer	0.00298	0.00298	CcSEcCtD
Vancomycin—Nervous system disorder—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Vancomycin—Thrombocytopenia—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—colon cancer	0.00295	0.00295	CcSEcCtD
Vancomycin—Tachycardia—Capecitabine—colon cancer	0.00295	0.00295	CcSEcCtD
Vancomycin—Vomiting—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Vancomycin—Skin disorder—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Vancomycin—Rash—Vincristine—colon cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Dermatitis—Vincristine—colon cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Headache—Vincristine—colon cancer	0.0029	0.0029	CcSEcCtD
Vancomycin—Vomiting—Irinotecan—colon cancer	0.00287	0.00287	CcSEcCtD
Vancomycin—Dizziness—Fluorouracil—colon cancer	0.00286	0.00286	CcSEcCtD
Vancomycin—Rash—Irinotecan—colon cancer	0.00285	0.00285	CcSEcCtD
Vancomycin—Dermatitis—Irinotecan—colon cancer	0.00284	0.00284	CcSEcCtD
Vancomycin—Chills—Methotrexate—colon cancer	0.00284	0.00284	CcSEcCtD
Vancomycin—Headache—Irinotecan—colon cancer	0.00283	0.00283	CcSEcCtD
Vancomycin—Hypotension—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Vancomycin—Erythema—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Nausea—Vincristine—colon cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Vomiting—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Insomnia—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Vancomycin—Rash—Fluorouracil—colon cancer	0.00273	0.00273	CcSEcCtD
Vancomycin—Dermatitis—Fluorouracil—colon cancer	0.00272	0.00272	CcSEcCtD
Vancomycin—Headache—Fluorouracil—colon cancer	0.00271	0.00271	CcSEcCtD
Vancomycin—Dyspnoea—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Vancomycin—Nausea—Irinotecan—colon cancer	0.00268	0.00268	CcSEcCtD
Vancomycin—Back pain—Methotrexate—colon cancer	0.00266	0.00266	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Vancomycin—Fatigue—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Vancomycin—Constipation—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Vancomycin—Pain—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Vancomycin—Nausea—Fluorouracil—colon cancer	0.00257	0.00257	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—colon cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Gastrointestinal pain—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Vancomycin—Urticaria—Capecitabine—colon cancer	0.0024	0.0024	CcSEcCtD
Vancomycin—Abdominal pain—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Vancomycin—Body temperature increased—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Vancomycin—Infection—Methotrexate—colon cancer	0.00223	0.00223	CcSEcCtD
Vancomycin—Hypersensitivity—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—colon cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—colon cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—colon cancer	0.00218	0.00218	CcSEcCtD
Vancomycin—Asthenia—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Vancomycin—Pruritus—Capecitabine—colon cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—colon cancer	0.002	0.002	CcSEcCtD
Vancomycin—Dizziness—Capecitabine—colon cancer	0.002	0.002	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Pain—Methotrexate—colon cancer	0.00192	0.00192	CcSEcCtD
Vancomycin—Vomiting—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Vancomycin—Rash—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Dermatitis—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Headache—Capecitabine—colon cancer	0.00189	0.00189	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—colon cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Nausea—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—colon cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Rash—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Headache—Methotrexate—colon cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Nausea—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
